Menu Close

Dermalog beats Semlex, others to $48M biometric passport deal in DRC

German biometrics firm Dermalog has won a contract worth US$48 million to produce biometric passports in the Democratic Republic of Congo (DRC), the firm has confirmed with Biometric Update following reports in Congolese media.

Further details are to emerge, but the announcement, ending around five months of speculation, reveals Belgium’s Semlex or subsidiary Locosem failed to win the new contract, after supplying passports to the country through thick and thin since 2016 (bar a few months’ standoff last year).

Dermalog’s new contract involves enrollment for passports as well as supplying the personalization system for producing each credential, suggesting a complete overhaul of the existing operation.

Details such as the cost of a passport to hopeful Congolese travelers are not yet known. Under Semlex, costs rose to $185 before falling again to $99 under its subsidiary Locosem last year. Semlex stint was the subject of much investigative reporting by Reuters, all the way back to 2017.

Dermalog has recently had its own issues with authorities in the Philippines over problems with the Land Transportation Office online portal. Delays have since been resolved.

The news emerges weeks after another biometrics deal with the DRC. Israel’s Pangea was awarded a $70 million PPP contract to devise a centralized automatic criminal biometrics identification system (ABIS). Pangea is also reported to have bid for the passport contract.

Other passport bidders, according to Africa Intelligence reporting in July, included IN Groupe and Toppan. German biometrics firm Dermalog has won a contract worth US$48 million to produce biometric passports in the Democratic Republic of Congo (DRC), the firm has confirmed with Biometric Update following reports in Congolese media.

Further details are to emerge, but the announcement, ending around five months of speculation, reveals Belgium’s Semlex or subsidiary Locosem failed to win the new contract, after supplying passports to the country through thick and thin since 2016 (bar a few months’ standoff last year).

Dermalog’s new contract involves enrollment for passports as well as supplying the personalization system for producing each credential, suggesting a complete overhaul of the existing operation.

Details such as the cost of a passport to hopeful Congolese travelers are not yet known. Under Semlex, costs rose to $185 before falling again to $99 under its subsidiary Locosem last year. Semlex stint was the subject of much investigative reporting by Reuters, all the way back to 2017.

Dermalog has recently had its own issues with authorities in the Philippines over problems with the Land Transportation Office online portal. Delays have since been resolved.

The news emerges weeks after another biometrics deal with the DRC. Israel’s Pangea was awarded a $70 million PPP contract to devise a centralized automatic criminal biometrics identification system (ABIS). Pangea is also reported to have bid for the passport contract.

Other passport bidders, according to Africa Intelligence reporting in July, included IN Groupe and Toppan.  Read More  Biometric Update 

Generated by Feedzy

Disclaimer

Innov8 is owned and operated by Rolling Rock Ventures. The information on this website is for general information purposes only. Any information obtained from this website should be reviewed with appropriate parties if there is any concern about the details reported herein. Innov8 is not responsible for its contents, accuracies, and any inaccuracies. Nothing on this site should be construed as professional advice for any individual or situation. This website includes information and content from external sites that is attributed accordingly and is not the intellectual property of Innov8. All feeds ("RSS Feed") and/or their contents contain material which is derived in whole or in part from material supplied by third parties and is protected by national and international copyright and trademark laws. The Site processes all information automatically using automated software without any human intervention or screening. Therefore, the Site is not responsible for any (part) of this content. The copyright of the feeds', including pictures and graphics, and its content belongs to its author or publisher.  Views and statements expressed in the content do not necessarily reflect those of Innov8 or its staff. Care and due diligence has been taken to maintain the accuracy of the information provided on this website. However, neither Innov8 nor the owners, attorneys, management, editorial team or any writers or employees are responsible for its content, errors or any consequences arising from use of the information provided on this website. The Site may modify, suspend, or discontinue any aspect of the RSS Feed at any time, including, without limitation, the availability of any Site content.  The User agrees that all RSS Feeds and news articles are for personal use only and that the User may not resell, lease, license, assign, redistribute or otherwise transfer any portion of the RSS Feed without attribution to the Site and to its originating author. The Site does not represent or warrant that every action taken with regard to your account and related activities in connection with the RSS Feed, including, without limitation, the Site Content, will be lawful in any particular jurisdiction. It is incumbent upon the user to know the laws that pertain to you in your jurisdiction and act lawfully at all times when using the RSS Feed, including, without limitation, the Site Content.  

Close Bitnami banner
Bitnami